United Therapeutics Corp

+0.39 (+0.20%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)8.93B
Current PE18.96
Forward PE 16.28
2yr Forward PE 12.17
See more stats
Estimates Current Quarter
Revenue$421.67 Million
Adjusted EPS$3.58
See more estimates
10-Day MA$203.97
50-Day MA$199.14
200-Day MA$180.79
See more pivots

United Therapeutics Corp Stock, NASDAQ:UTHR

1040 Spring Street, Silver Spring, Maryland 20910
United States of America
Phone: +1.301.608.9292
Number of Employees: 950


United Therapeutics Corp. operates as a biotechnology company, which engages in the development and commercialization of products for patients with chronic and life-threatening diseases. The firm markets and sells commercial therapies to treat pulmonary arterial hypertension and high-risk neuroblastoma. It also involves in the research and development of new indications and delivery devices for its product and for the organ transplantation-related technologies. The company was founded by Martine A. Rothblatt on June 26, 1996 and is headquartered in Silver Spring, MD.